EMJ GOLD: Pharma marketing, medical & more

EMJ
  • 5.0（2則評分）
  • 商業
  • 每週更新
EMJ GOLD: Pharma marketing, medical & more

Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm. Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.

  1. S08 E08: Alfasigma’s Patrick Oliver on the company’s new chapter in the UK

    5 天前

    S08 E08: Alfasigma’s Patrick Oliver on the company’s new chapter in the UK

    In this episode, Isabel welcomes Patrick Oliver, General Manager for the UK and Ireland at Alfasigma, to explore the company’s exciting entry into the UK market and the evolving landscape of healthcare in the country.   In the conversation, Patrick brings his wealth of industry experience to share his vision for Alfasigma’s future, the potential he sees in the UK healthcare market and the unique challenges ahead. They also delve into Lord Darzi’s report on the NHS, examining its implications for healthcare reform and innovation.  A little more on GOLD’s guest…  Patrick Oliver is Alfasigma’s General Manager for the UK & Ireland, a role he’s held since the company’s launch in the UK in early 2024. He has 36 years’ experience in the industry, with 16 years specifically in market access. Prior to joining Alfasigma, Patrick worked in market access for a number of large pharmaceutical companies including Johnson & Johnson, AbbVie and Abbott.

    21 分鐘
  2. S08 E07: What should marketing and medical affairs invest in for Q4?

    11月12日

    S08 E07: What should marketing and medical affairs invest in for Q4?

    As 2024 draws to a close, what should pharma teams be focusing their budgets on for the final quarter of the year? Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024. As teams finalise their budgets and plan for the final quarter and year ahead, this conversation brings insights into how strategies like personalised engagement, thought leadership and interactive, on-demand content are making an impact. With real-life examples, learn about the tools you can invest in to end the year on a high.

    9 分鐘
  3. S08 E06: Ipsen’s Jennifer Schranz on rethinking rare disease for women

    10月29日

    S08 E06: Ipsen’s Jennifer Schranz on rethinking rare disease for women

    In this new episode, the team welcomes Jennifer Schranz, Senior Vice President, Global Head of Rare Diseases, Ipsen, to investigate the burden faced by women with rare diseases. Together, Jennifer and Jade discuss how the industry can address challenging rare diseases and making a meaningful impact on patients’ lives, the double jeopardy that women with rare diseases face, recent breakthroughs in the space and much more.

    24 分鐘

  4. 10月22日

    S08 E05: ARS' Richard Lowenthal on his mission to transform allergy care

    In the latest episode of our podcast, we welcome Richard Lowenthal, CEO, ARS Pharmaceuticals, to explore the company’s mission to address unmet needs in allergy care. During the conversation, Richard shares insights into his early career at the FDA and the regulatory challenges he faced in bringing ARS’s new nasal spray to treat severe allergic reactions to market. He also discusses the future direction of the company and much more. A little more on EMJ GOLD’s guest… Richard Lowenthal is the co-founder, President, and CEO, ARS Pharmaceuticals, with a leadership role since the company’s inception in 2015. Before ARS, he founded Pacific-Link Regulatory Consulting, where he contributed to the development of their diazepam nasal spray. Richard’s extensive background includes senior roles at Cadence Pharmaceuticals, Maxim Pharmaceuticals and Janssen Research Foundation, as well as work as a chemist at the FDA. He holds an M.Sc. in organic chemistry and an MSEL and has chaired the American Association of Pharmaceutical Scientists.

    21 分鐘
  5. Astellas’ Martina Dempsey on achieving equal footing for women in pharma

    10月15日

    Astellas’ Martina Dempsey on achieving equal footing for women in pharma

    In the latest episode, Jade sits down with Martina Dempsey, Vice President of Commercial Strategy and Operations at Astellas Europe, to discuss empowering women in the pharmaceutical industry.  They explore how pharma meets the needs and values of young graduates, the ongoing challenges women face in securing leadership roles, the critical impact of mentorship on career development and much more.

    29 分鐘
  6. S08 E03: World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic

    10月8日

    S08 E03: World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic

    In this episode, Isabel is joined by Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim, to mark World Mental Health Day on 10 October 2024.  Their conversation dives into the unique challenges faced by those living with serious mental illnesses, the impact of media representation and the role pharma can play in transforming treatment and quality of life for these patients.  Central to their discussion is the importance of amplifying lived experiences, a key focus of Boehringer’s new campaign, Schizophrenia in Real Life: Stories of Challenges, Resilience, and Hope.  The campaign aims to build greater understanding and acceptance of the condition by highlighting the strength and resilience of those living with it.

    24 分鐘
  7. S08 E02: ViiV Healthcare’s Jean-Bernard Simeon on ending the HIV epidemic

    10月2日

    S08 E02: ViiV Healthcare’s Jean-Bernard Simeon on ending the HIV epidemic

    This week, Jean-Bernard Simeon, Senior Vice President and Head, ViiV Healthcare Europe, sits down with the EMJ GOLD team to share his thoughts on the current landscape for patients with HIV in Europe.   Together, JB and Jade explore the UNAIDS roadmap to end the HIV epidemic by 2030, the barriers faced by people living with HIV in Europe, stigmas still surrounding the condition and much more.

    28 分鐘
  8. S08 E01: Moderna’s Chantal Friebertshäuser on improving vaccine confidence

    9月24日

    S08 E01: Moderna’s Chantal Friebertshäuser on improving vaccine confidence

    The EMJ GOLD podcast is back! In the first episode of season 8, Jade sits down with Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna, to discuss how Europe can combat the recent erosion of trust in vaccines. Together, the two explore the role of governments in addressing vaccine hesitancy, improving vaccine education amongst various groups, how a culture of collaboration can improve the current vaccine landscape and much more.

    26 分鐘
顯示全部 (279)

評分與評論

5
（滿分 5 顆星）
2 則評分

簡介

Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm. Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.

資訊

你可能也會喜歡

  • 兒少不宜、The Rest Is Politics
    政治
    政治

    每週更新兩次

若要收聽兒少不宜的單集，請登入帳號。

隨時掌握此節目最新消息

登入或註冊後，即可追蹤節目、儲存單集和掌握最新資訊。
選取國家或地區

非洲、中東和印度

亞太地區

歐洲

拉丁美洲與加勒比海地區

美國與加拿大